Please assess the completion status of the following clinical trial:

Trial Title: The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV infected woman~* 18 - 40 years of age~* able and willing to sign Informed Consent~* pregnant for a maximum of 31 weeks~Exclusion Criteria:~* history of sensitivity/idiosyncrasy to the drug~* relevant history of interference with drug metabolism~* inability to understand trial procedures~* abnormal specific serum levels~* use of specific concomitant medications~* active hepatobiliary or hepatic disease~* previous failure of saquinavir/ritonavir regimen

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).